托珠单抗治疗难治性成人斯蒂尔病的疗效；2例报告。 - Suppr

Suppr

超能文献

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

作者信息

Andrade-Ortega Lilia, Irazoque-Palazuelos Fedra, Muñoz-López Sandra, Rosales-Don Pablo Victor M

机构信息

Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D.F., México.

出版信息

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

DOI:10.1016/j.reuma.2013.05.004

PMID:24076178

Abstract

摘要

相似文献

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.

Intern Med. 2015;54(20):2675-9. doi: 10.2169/internalmedicine.54.4935. Epub 2015 Oct 15.

[Tocilizumab effectiveness in adult Still's disease].

Med Clin (Barc). 2012 Jan 21;138(1):42-3. doi: 10.1016/j.medcli.2011.04.002. Epub 2011 May 24.

Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.

Mod Rheumatol. 2016;26(2):297-301. doi: 10.3109/14397595.2014.899178. Epub 2014 Apr 3.

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.

Ann Rheum Dis. 2018 Dec;77(12):1720-1729. doi: 10.1136/annrheumdis-2018-213920. Epub 2018 Oct 2.

Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.

Acta Medica (Hradec Kralove). 2016;59(1):22-5. doi: 10.14712/18059694.2016.51.

Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.

Joint Bone Spine. 2015 Mar;82(2):136-7. doi: 10.1016/j.jbspin.2014.03.010. Epub 2014 Dec 29.

Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):141-2.

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.

Mod Rheumatol. 2009;19(1):69-72. doi: 10.1007/s10165-008-0116-2. Epub 2008 Sep 2.

[Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].

Presse Med. 2011 Jul-Aug;40(7-8):e333-7. doi: 10.1016/j.lpm.2011.03.012. Epub 2011 May 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.

Intern Med. 2015;54(20):2675-9. doi: 10.2169/internalmedicine.54.4935. Epub 2015 Oct 15.

[Tocilizumab effectiveness in adult Still's disease].

Med Clin (Barc). 2012 Jan 21;138(1):42-3. doi: 10.1016/j.medcli.2011.04.002. Epub 2011 May 24.

Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.

Mod Rheumatol. 2016;26(2):297-301. doi: 10.3109/14397595.2014.899178. Epub 2014 Apr 3.

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.

Ann Rheum Dis. 2018 Dec;77(12):1720-1729. doi: 10.1136/annrheumdis-2018-213920. Epub 2018 Oct 2.

Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.

Acta Medica (Hradec Kralove). 2016;59(1):22-5. doi: 10.14712/18059694.2016.51.

Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.

Joint Bone Spine. 2015 Mar;82(2):136-7. doi: 10.1016/j.jbspin.2014.03.010. Epub 2014 Dec 29.

Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):141-2.

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.

Mod Rheumatol. 2009;19(1):69-72. doi: 10.1007/s10165-008-0116-2. Epub 2008 Sep 2.

[Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].

Presse Med. 2011 Jul-Aug;40(7-8):e333-7. doi: 10.1016/j.lpm.2011.03.012. Epub 2011 May 7.

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

作者信息

Andrade-Ortega Lilia, Irazoque-Palazuelos Fedra, Muñoz-López Sandra, Rosales-Don Pablo Victor M

机构信息

Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D.F., México.

出版信息

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

DOI:10.1016/j.reuma.2013.05.004

PMID:24076178

Abstract

摘要